InMed Pharmaceuticals Inc. (NASDAQ: INM)
$0.28
+0.0090 ( +3.37% ) 1.0M
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Market Data
Open
$0.28
Previous close
$0.27
Volume
1.0M
Market cap
$2.44M
Day range
$0.26 - $0.29
52 week range
$0.21 - $2.08
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 22 | Oct 30, 2023 |
| def | Proxies and info statements | 6 | Oct 27, 2023 |
| 8-k | 8K-related | 14 | Oct 24, 2023 |
| 8-k | 8K-related | 15 | Sep 29, 2023 |
| 10-k | Annual reports | 115 | Sep 29, 2023 |
| nt | Quarterly Reports | 1 | Sep 29, 2023 |
| 8-k | 8K-related | 13 | Sep 25, 2023 |
| 8-k | 8K-related | 15 | Sep 25, 2023 |
| 8-k | 8K-related | 15 | Sep 08, 2023 |
| 4 | Insider transactions | 1 | Aug 31, 2023 |